{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Folate receptor",
      "Ovarian peritoneal carcinomatosis",
      "Photodynamic therapy",
      "Photosensitizer",
      "Targeted-therapy"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "26200606",
  "DateCompleted": {
    "Year": "2016",
    "Month": "12",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "04",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2015",
        "Month": "07",
        "Day": "19"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.pdpdt.2015.07.005",
      "S1572-1000(15)30006-5"
    ],
    "Journal": {
      "ISSN": "1873-1597",
      "JournalIssue": {
        "Volume": "13",
        "PubDate": {
          "Year": "2016",
          "Month": "Mar"
        }
      },
      "Title": "Photodiagnosis and photodynamic therapy",
      "ISOAbbreviation": "Photodiagnosis Photodyn Ther"
    },
    "ArticleTitle": "Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study.",
    "Pagination": {
      "StartPage": "130",
      "EndPage": "138",
      "MedlinePgn": "130-138"
    },
    "Abstract": {
      "AbstractText": [
        "Ovarian cancer's prognosis remains dire after primary therapy. Recurrence rate is disappointingly high as 60% of women with epithelial ovarian cancer considered in remission will develop recurrent disease within 5 years. Special attention to undetected peritoneal metastasis during surgery is necessary as they are the main predictive factors of recurrences. Folate Receptor \u03b1 (FR\u03b1) shows promising prospects in targeting ovarian cancerous cells and intraperitoneal photodynamic therapy (PDT) could be a solution in addition to macroscopic cytoreductive surgery to treat peritoneal micrometastasis. The aim of this preclinical study is to assess the specificity of a folate-targeted photosensitizer for ovarian peritoneal micrometastasis.",
        "We used the NuTu-19 epithelial ovarian cancer cell line to induce peritoneal carcinomatosis in female Fischer 344 rats. Three groups of 6 rats were studied (Control (no photosensitizer)/Non-conjugated photosensitizer (Porph)/Folate-conjugated photosensitizer (Porph-s-FA)). Four hours after the administration of the photosensitizer, animals were sacrificed and intraperitoneal organs tissues were sampled. FR\u03b1 tissue expression was evaluated by immunohistochemistry. Tissue incorporation of photosensitizers was assessed by confocal microscopy and tissue quantification.",
        "FR\u03b1 is overexpressed in tumor, ovary, and liver whereas, peritoneum, colon, small intestine, and kidney do not express it. Cytoplasmic red endocytosis vesicles observed by confocal microscopy are well correlated to FR\u03b1 tissue expression. Photosensitizer tissue quantification shows a mean tumor-to-normal tissue ratio of 9.6.",
        "We demonstrated that this new generation folate-targeted photosensitizer is specific of epithelial ovarian peritoneal metastasis and may allow the development of efficient and safe intraperitoneal PDT procedure."
      ],
      "CopyrightInformation": "Copyright \u00a9 2015 Elsevier B.V. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Univ. Lille, Inserm, CHU Lille, U1189 - ONCO-THAI - Image Assisted Laser Therapy for Oncology, F-59000 Lille, France; Department of Gynecology, University of Lille, 59000 Lille, France. Electronic address: henriazais@gmail.com."
          }
        ],
        "LastName": "Aza\u00efs",
        "ForeName": "Henri",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre Fran\u00e7ais des Porphyries, Assistance Publique - H\u00f4pitaux de Paris, H\u00f4pital Louis Mourier, Colombes, France and INSERM U1149, Paris Diderot University, 75018 Paris, France."
          }
        ],
        "LastName": "Schmitt",
        "ForeName": "Caroline",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Plate-Forme D'imagerie Cellulaire BICEL - IFR 114, P\u00f4le Recherche, University of Lille, 59000 Lille, France."
          }
        ],
        "LastName": "Tardivel",
        "ForeName": "Meryem",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre de Biologie-Pathologie, University of Lille, 59000 Lille, France."
          }
        ],
        "LastName": "Kerdraon",
        "ForeName": "Olivier",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratoire R\u00e9actions et G\u00e9nie des Proc\u00e9d\u00e9s, UMR 7274CNRS - University of Lorraine, France."
          }
        ],
        "LastName": "Stallivieri",
        "ForeName": "Aur\u00e9lie",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratoire R\u00e9actions et G\u00e9nie des Proc\u00e9d\u00e9s, UMR 7274CNRS - University of Lorraine, France."
          }
        ],
        "LastName": "Frochot",
        "ForeName": "C\u00e9line",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Univ. Lille, Inserm, CHU Lille, U1189 - ONCO-THAI - Image Assisted Laser Therapy for Oncology, F-59000 Lille, France."
          }
        ],
        "LastName": "Betrouni",
        "ForeName": "Nacim",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Univ. Lille, Inserm, CHU Lille, U1189 - ONCO-THAI - Image Assisted Laser Therapy for Oncology, F-59000 Lille, France; Department of Gynecology, University of Lille, 59000 Lille, France."
          }
        ],
        "LastName": "Collinet",
        "ForeName": "Pierre",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Univ. Lille, Inserm, CHU Lille, U1189 - ONCO-THAI - Image Assisted Laser Therapy for Oncology, F-59000 Lille, France."
          }
        ],
        "LastName": "Mordon",
        "ForeName": "Serge",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Photodiagnosis Photodyn Ther",
    "NlmUniqueID": "101226123",
    "ISSNLinking": "1572-1000"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Folate Receptor 1"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Photosensitizing Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Porphyrins"
    },
    {
      "RegistryNumber": "935E97BOY8",
      "NameOfSubstance": "Folic Acid"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Carcinoma, Ovarian Epithelial"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line, Tumor"
    },
    {
      "QualifierName": [
        "drug effects",
        "radiation effects"
      ],
      "DescriptorName": "Cell Survival"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Evaluation, Preclinical"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Folate Receptor 1"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "pharmacokinetics"
      ],
      "DescriptorName": "Folic Acid"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Injections, Intraperitoneal"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Molecular Targeted Therapy"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Neoplasms, Glandular and Epithelial"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Ovarian Neoplasms"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism",
        "secondary"
      ],
      "DescriptorName": "Peritoneal Neoplasms"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Photochemotherapy"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "pharmacokinetics"
      ],
      "DescriptorName": "Photosensitizing Agents"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Porphyrins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats, Inbred F344"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ]
}